Healthcare provider profile · identity verified

Yoandra Carralero

Nurse Practitioner · MIAMI, FL · NPI 1962101907

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	1397	257
Vitamin D2	Ergocalciferol (Vitamin D2)	1201	201
Donepezil Hcl	Donepezil Hcl	869	183
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	824	177
Atorvastatin Calcium	Atorvastatin Calcium	804	233
Alendronate Sodium	Alendronate Sodium	688	100
Fenofibrate	Fenofibrate	671	165
Levothyroxine Sodium	Levothyroxine Sodium	471	89
Montelukast Sodium	Montelukast Sodium	468	90
Losartan Potassium	Losartan Potassium	446	113
Metformin Hcl	Metformin Hcl	423	79
Lisinopril	Lisinopril	418	91
Albuterol Sulfate Hfa	Albuterol Sulfate	413	170
Amlodipine Besylate	Amlodipine Besylate	401	99
Escitalopram Oxalate	Escitalopram Oxalate	398	108
Rosuvastatin Calcium	Rosuvastatin Calcium	388	117
Famotidine	Famotidine	345	87
Omeprazole	Omeprazole	339	79
Folic Acid	Folic Acid	325	48
Memantine Hcl	Memantine Hcl	305	62
Hydrochlorothiazide	Hydrochlorothiazide	290	67
Mirtazapine	Mirtazapine	275	64
Metoprolol Succinate	Metoprolol Succinate	232	55
Fluticasone Propionate	Fluticasone Propionate	229	119
Sertraline Hcl	Sertraline Hcl	218	49
Azithromycin	Azithromycin	201	164
Methocarbamol	Methocarbamol	185	138
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	174	46
Pantoprazole Sodium	Pantoprazole Sodium	174	41
Buspirone Hcl	Buspirone Hcl	159	22
Tamsulosin Hcl	Tamsulosin Hcl	156	34
Trazodone Hcl	Trazodone Hcl	152	41
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	142	42
Glipizide	Glipizide	139	26
Levofloxacin	Levofloxacin	138	112
Enalapril Maleate	Enalapril Maleate	123	26
Carvedilol	Carvedilol	121	24
Dicyclomine Hcl	Dicyclomine Hcl	109	19
Naproxen	Naproxen	109	90
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	106	87
Duloxetine Hcl	Duloxetine Hcl	101	19
Metoprolol Tartrate	Metoprolol Tartrate	99	22
Atrovent Hfa	Ipratropium Bromide	97	43
Furosemide	Furosemide	97	25
Meclizine Hcl	Meclizine Hcl	95	31
Bumetanide	Bumetanide	92	18
Methylprednisolone	Methylprednisolone	91	73
Glimepiride	Glimepiride	88	19
Glipizide Er	Glipizide	85	16
Sildenafil Citrate	Sildenafil Citrate	84	11
Pentoxifylline	Pentoxifylline	83	16
Clopidogrel	Clopidogrel Bisulfate	82	15
Chlorthalidone	Chlorthalidone	80	16
Atenolol	Atenolol	79	16
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	79	16
Clobetasol Propionate	Clobetasol Propionate	74	24
Ciclopirox	Ciclopirox	73	21
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	72	31
Simvastatin	Simvastatin	72	24
Trueplus Pen Needle	Pen Needle, Diabetic	71	13
Irbesartan	Irbesartan	67	13
Alprazolam	Alprazolam	65	14
Temazepam	Temazepam	64	18
Citalopram Hbr	Citalopram Hydrobromide	63	19
Allopurinol	Allopurinol	60	12
Metformin Hcl Er	Metformin Hcl	60	20
Quetiapine Fumarate	Quetiapine Fumarate	60	17
Clonidine Hcl	Clonidine Hcl	59	16
Finasteride	Finasteride	59	11
Triamcinolone Acetonide	Triamcinolone Acetonide	57	29
Clonazepam	Clonazepam	56	11
Metformin Er Osmotic	Metformin Hcl	52	15
Hydralazine Hcl	Hydralazine Hcl	51	11
Nitroglycerin	Nitroglycerin	50	21
Mupirocin	Mupirocin	49	44
Tadalafil	Tadalafil	49	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	48	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Latanoprost	Latanoprost	44	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	42	suppressed
Nifedipine Er	Nifedipine	40	11
Ketoconazole	Ketoconazole	39	11
Ezetimibe	Ezetimibe	38	12
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Warfarin Sodium	Warfarin Sodium	37	suppressed
Methimazole	Methimazole	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Metronidazole	Metronidazole	33	23
Propranolol Hcl	Propranolol Hcl	33	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	33	suppressed
Ammonium Lactate	Ammonium Lactate	32	16
Spironolactone	Spironolactone	32	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	30	13
Eliquis	Apixaban	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	28	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	24
Valsartan	Valsartan	28	suppressed
Acyclovir	Acyclovir	26	suppressed
Benzonatate	Benzonatate	26	25
Carbamazepine	Carbamazepine	26	suppressed
Potassium Chloride	Potassium Chloride	26	suppressed
Cilostazol	Cilostazol	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	25	11
Baclofen	Baclofen	24	suppressed
Ibuprofen	Ibuprofen	24	20
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	23	19
Acetaminophen-Codeine	Acetaminophen With Codeine	22	18
Dapagliflozin	Dapagliflozin Propanediol	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	20
Verapamil Hcl	Verapamil Hcl	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	21	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Nifedipine	Nifedipine	21	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Pravastatin Sodium	Pravastatin Sodium	19	suppressed
Rivastigmine	Rivastigmine Tartrate	19	suppressed
Cephalexin	Cephalexin	18	18
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Hydrocortisone	Hydrocortisone	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Nystatin	Nystatin	18	12
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	14
Farxiga	Dapagliflozin Propanediol	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Torsemide	Torsemide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Fluticasone-Salmeterol Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Sps	Sodium Polystyrene Sulfon/Sorb	15	12
Timolol Maleate	Timolol Maleate	15	suppressed
Erythromycin	Erythromycin Base	14	13
Labetalol Hcl	Labetalol Hcl	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Alogliptin	Alogliptin Benzoate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Prednisone	Prednisone	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error